Search For "patient options"
USFDA moves to accelerate biosimilar development and lower drug costs
Updated : 4 months, 2 weeks ago IST
The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases.
Read More